Date Insider Type Main position Quantity % Market Cap. Importance
4/21/21 Other 0 0% -
4/21/21 Other

Chief Executive Officer

0 0%
4/21/21 Other 0 0% -
Change 5-day change 1-year change 3-year change Capi.($)
-.--%-90.00% - - 59
-0.71%-6.35%-2.99%+9.37% 45.48B
+0.21%-2.98%+337.74%+520.30% 43.68B
+1.74%-2.24%+39.82%+20.85% 43.09B
+1.38%-3.28%+6.84%+73.19% 39.4B
-1.44%-5.26%+8.97%+39.76% 31.91B
+0.87%-2.60% - - 17.31B
+0.75%-0.64%+19.75%+108.58% 16.4B
-0.31%-2.78%+10.78%+30.20% 14.24B
+1.93%-3.55%+82.00%+36.66% 13.28B
Average +0.44%-3.20%+62.86%+104.87% 29.42B
Weighted average by Cap. +0.41%-3.50%+74.57%+124.86%
Logo Avisa Diagnostics Inc.
Avisa Diagnostics Inc is a United States-based clinical-stage medical device company. The Company is engaged in developing drug/device biomarker technology platform that enables the ultra rapid detection of virulent bacterial pathogens, detecting and monitoring bacterial load after the patient inhales or ingests its drug substrates.
Employees
-
  1. Stock Market
  2. Stocks
  3. FOGCF Stock
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!